Posts

Showing posts with the label Lambert-Eaton myasthenic syndrome with and without cancer

Lambert Eaton Myasthenic Syndrome (LEMS): An Autoimmune Syndrome Causing Muscle Weakness

Lambert Eaton Myasthenic Syndrome (LEMS): An Autoimmune Syndrome Causing Muscle Weakness Lambert Eaton Myasthenic Syndrome belongs to the class of disorders referred to as neuromuscular transmission disorders. That is to say, that this group of diseases affects the ability of the nerves to communicate with the muscles and thus leads to muscle weakness. Lambert Eaton Myasthenic Syndrome (LEMS) is also an autoimmune disorder because it is a product of the body that is acting to cause the disorder. In other words, the body is acting against itself to cause disease. Finally, LEMS is often a paraneoplastic disorder. The term paraneoplastic refers to a disease that is indirectly caused by a neoplasm or cancer. While we will discuss LEMS in detail, it is important to know that a variety of paraneoplastic syndromes exist and can be the first signs of a malignancy. PATHOPHYSIOLOGY In order to understand LEMS, it is necessary to first understand how muscles are made to work. We will ta

Wall Street Journal Catalyst Pharmaceutical Partners, Inc. Announces Closing of Previously Announced Public Offering

Catalyst Pharmaceutical Partners, Inc. Announces Closing of Previously Announced Public Offering CORAL GABLES, Fla., April 8, 2014 (GLOBE NEWSWIRE) -- Catalyst Pharmaceutical Partners, Inc. (Nasdaq:CPRX) today reported that it has closed its previously announced public offering of shares of its common stock. The Company sold

Free e-Book Lambert-Eaton myasthenic syndrome with and without cancer.

Differences in clinical features between the Lambert-Eaton myasthenic syndrome with and without cancer: an analysis of 227 published cases THIS IS A LINK TO A GREAT FREE ONLINE 56 PAGE E- BOOK TO PRINT OR READ. Link> Here!                https://openaccess.leidenuniv.nl/bitstream/handle/1887/4275/05.pdf?sequence=15

PNSEURONET international group of neurologists interested in the field of paraneoplastic syndromes.....

In November 2002, an international group of neurologists interested in the field of paraneoplastic syndromes (PNS) established the PNS Euronetwork supported by a grant from the European Union. The aim is to assist neurologists in the diagnosis and classification of Paraneoplastic symptoms by providing rigorous diagnostic criteria for the different conditions, to interchange information among the different centres, and to facilitate the pooling of patients for clinical trials.   This site contains a section on LEMS under paraneoplastic syndromes of the neuromuscular junction and muscle www.pnseuronet.org